(Q38090542)

28 August 2017

title

Current status of cell-based therapy for heart failure (English)

1 reference

28 August 2017

0 references

2

Ulf Landmesser

1 reference

28 August 2017

Philipp Jakob

1

1 reference

28 August 2017

publication date

1 June 2013

1 reference

Current heart failure reports

28 August 2017

published in

1 reference

28 August 2017

volume

10

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

165-176

1 reference

Heart regeneration in zebrafish

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Evidence for cardiomyocyte renewal in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Stem-cell therapy for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Derivation and potential applications of human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Guidelines and techniques for the generation of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

The promise of induced pluripotent stem cells in research and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Adult cardiac stem cells are multipotent and support myocardial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Stem cell niches in the adult mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Islet1 cardiovascular progenitors: a single source for heart lineages?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Aging and disease as modifiers of efficacy of cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Bone marrow cells regenerate infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Role of paracrine factors in stem and progenitor cell mediated cardiac repair and tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Intramyocardial, autologous CD34+ cell therapy for refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Mesenchymal stem cells as trophic mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Preconditioning and stem cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Pervasive roles of microRNAs in cardiovascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Functional screening identifies miRNAs inducing cardiac regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Role of microRNAs in stem/progenitor cells and cardiovascular repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-013-0134-Z

Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction.

21 January 2018

1 reference

12 December 2020

Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production

1 reference

12 December 2020

Short- and long-term outcomes of intracoronary and endogenously mobilized bone marrow stem cells in the treatment of ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials

1 reference

12 December 2020

Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice

1 reference

12 December 2020

Isolation and expansion of adult cardiac stem cells from human and murine heart

1 reference

12 December 2020

Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.

1 reference

12 December 2020

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

1 reference

12 December 2020

Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction

1 reference

12 December 2020

Mixed results for bone marrow–derived cell therapy for ischemic heart disease

1 reference

12 December 2020

Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction

1 reference

12 December 2020

Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study

1 reference

12 December 2020

10.1007/S11897-013-0134-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1009346962

0 references

1 reference